ロード中...

Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor α antibody

Few patients with Behçet's syndrome have gastrointestinal ulceration. Such patients are difficult to treat and have a higher mortality. Faced with refractory symptoms in two patients with intestinal Behçet's, we used the tumour necrosis factor α (TNF-α) monoclonal antibody infliximab to in...

詳細記述

保存先:
書誌詳細
主要な著者: Travis, S, Czajkowski, M, McGovern, D, Watson, R, Bell, A
フォーマット: Artigo
言語:Inglês
出版事項: 2001
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1728519/
https://ncbi.nlm.nih.gov/pubmed/11600479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.49.5.725
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!